|
EP2295449A1
|
|
PLGF-1 in homodimeric form
|
|
WO2008110351A2
|
|
Use of (r) and (s)-2-aryl-propionic acid derivatives as antiseptic agents
|
|
KR20090010979A
|
|
(2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them
|
|
CN101360706A
|
|
(R)-arylalkylamino derivatives and pharmaceutical compositions containing them
|
|
CN101305096A
|
|
Novel selection system
|
|
EP1900752A1
|
|
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
|
CN101146764A
|
|
Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
|
|
EP1579859A1
|
|
Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
|
|
HU0600336A2
|
|
2-aryl-propionic acids and pharmaceutical compositions containing them
|
|
HU0303221A2
|
|
Apparatus nozzle system and method for micron and submicron particle formation
|
|
SK9732003A3
|
|
Use of (R)-ibuprofen methanesulfonamide and salts thereof
|
|
HU0301497A2
|
|
1,3-dioxolanes with antitussive activity
|
|
EP0935961A2
|
|
(R)-2-(3-Benzoylphenyl)propionic acid salts and pharmaceutical preparations containing them
|
